85 related articles for article (PubMed ID: 22186784)
1. c-MYB and TGFβ: EMT's dynamic duo in breast cancer.
Sala A
Cell Cycle; 2012 Jan; 11(1):17. PubMed ID: 22186784
[No Abstract] [Full Text] [Related]
2. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
[TBL] [Abstract][Full Text] [Related]
3. Myb: getting involved in EMT.
Ramsay R
Cell Cycle; 2012 Feb; 11(3):433-4. PubMed ID: 22293402
[No Abstract] [Full Text] [Related]
4. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
[TBL] [Abstract][Full Text] [Related]
5. A supervised network analysis on gene expression profiles of breast tumors predicts a 41-gene prognostic signature of the transcription factor MYB across molecular subtypes.
Liu LY; Chang LY; Kuo WH; Hwa HL; Chang KJ; Hsieh FJ
Comput Math Methods Med; 2014; 2014():813067. PubMed ID: 24639887
[TBL] [Abstract][Full Text] [Related]
6. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
[TBL] [Abstract][Full Text] [Related]
7. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
8. Regulation of c-myb expression in ML-1 human myeloblastic leukemia cells by c-ets-1 protein.
Bloch A; Liu XM; Wang LG
Adv Enzyme Regul; 1995; 35():35-41. PubMed ID: 7572352
[TBL] [Abstract][Full Text] [Related]
9. c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells.
Chen L; Xu S; Zeng X; Li J; Yin W; Chen Y; Shao Z; Jin W
Acta Biochim Biophys Sin (Shanghai); 2010 Jan; 42(1):1-7. PubMed ID: 20043041
[TBL] [Abstract][Full Text] [Related]
10. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
11. C-myb, but not B-myb, upregulates type I collagen gene expression in human fibroblasts.
Piccinini G; Golay J; Flora A; Songia S; Luchetti M; Gabrielli A; Introna M
J Invest Dermatol; 1999 Feb; 112(2):191-6. PubMed ID: 9989795
[TBL] [Abstract][Full Text] [Related]
12. HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms.
Arnal-Estapé A; Tarragona M; Morales M; Guiu M; Nadal C; Massagué J; Gomis RR
Cancer Res; 2010 Dec; 70(23):9927-36. PubMed ID: 21098707
[TBL] [Abstract][Full Text] [Related]
13. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
14. MYB rearrangement and immunohistochemical expression in adenomyoepithelioma of the breast: a comparison with adenoid cystic carcinoma.
Baraban E; Zhang PJ; Jaffer S; Lubin D; Feldman M; Bleiweiss IJ; Nayak A
Histopathology; 2018 Dec; 73(6):897-903. PubMed ID: 30003572
[TBL] [Abstract][Full Text] [Related]
15. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.
Poling JS; Yonescu R; Subhawong AP; Sharma R; Argani P; Ning Y; Cimino-Mathews A
Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281
[TBL] [Abstract][Full Text] [Related]
16. New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.
Hugo HJ; Saunders C; Ramsay RG; Thompson EW
J Mammary Gland Biol Neoplasia; 2015 Dec; 20(3-4):109-19. PubMed ID: 26193871
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB.
Ramsay RG; Friend A; Vizantios Y; Freeman R; Sicurella C; Hammett F; Armes J; Venter D
Cancer Res; 2000 Apr; 60(7):1805-9. PubMed ID: 10766162
[TBL] [Abstract][Full Text] [Related]
19. Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
Jin W; Liu Y; Chen L; Zhu H; Di GH; Ling H; Wu J; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 125(3):699-713. PubMed ID: 20364308
[TBL] [Abstract][Full Text] [Related]
20. Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation.
Wang LG; Liu XM; Li ZR; Denstman S; Bloch A
Cell Growth Differ; 1994 Nov; 5(11):1243-51. PubMed ID: 7848925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
